Source:http://linkedlifedata.com/resource/pubmed/id/11315594
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-4-23
|
pubmed:abstractText |
The distribution of 3-[123I]iodo-L-alpha-methyltyrosine (123I-3-IMT) in the tumour region of 21 patients with clinically suspected recurrent squamous cell head and neck carcinoma was studied. Single-photon emission tomography (SPET) imaging of the head and neck region was performed 10 min after the injection of 130-170 MBq 123I-3-IMT using a dual-detector gamma camera. Images were interpreted visually and classified as positive or negative for recurrent disease. In addition, target to background ratios (T/B) were measured using semi-automated region of interest analysis. IMT-SPET results were compared with the data derived from clinicopathological follow-up. IMT-SPET detected recurrent disease in 14 of 15 patients (sensitivity 93%). T/B ratios ranged between 1.5 and 2.4 (mean 1.88). One patient with a small tumour (1.2 cm) had a false-negative result. This is attributed to the limited spatial resolution of the SPET system. Five of six patients were correctly diagnosed to be negative for tumour recurrence. T/B ratios ranged between 1.2 and 1.4 (mean 1.30). In one patient IMT-SPET was positive without evidence of recurrence based on clinicopathological follow up. This finding was probably due to uptake into inflammatory tissue. IMT-SPET appears to be a sensitive tool (93%) for the detection of recurrent head and neck squamous cell carcinoma. Further studies with 123I-3-IMT as a metabolic tracer for the detection of head and neck cancer recurrence using SPET are recommended.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0340-6997
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
282-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11315594-Adult,
pubmed-meshheading:11315594-Aged,
pubmed-meshheading:11315594-Aged, 80 and over,
pubmed-meshheading:11315594-Carcinoma, Squamous Cell,
pubmed-meshheading:11315594-Female,
pubmed-meshheading:11315594-Follow-Up Studies,
pubmed-meshheading:11315594-Head and Neck Neoplasms,
pubmed-meshheading:11315594-Humans,
pubmed-meshheading:11315594-Image Processing, Computer-Assisted,
pubmed-meshheading:11315594-Male,
pubmed-meshheading:11315594-Methyltyrosines,
pubmed-meshheading:11315594-Middle Aged,
pubmed-meshheading:11315594-Neoplasm Recurrence, Local,
pubmed-meshheading:11315594-Radiopharmaceuticals,
pubmed-meshheading:11315594-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
2001
|
pubmed:articleTitle |
Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
|
pubmed:affiliation |
Department of Nuclear Medicine, Academisch Ziekenhuis Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Jette, Brussels, Belgium. nucgdxl@az.vub.ac.be
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|